We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current EFTR market cap is 5.51M. The company's latest EPS is USD -11.9529 and P/E is -0.15.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 867k | 675k | 0 | 0 | 0 |
| Operating Income | -9.25M | -8.72M | -9.54M | -7.86M | -7.86M |
| Net Income | -9.56M | -9.26M | -10.01M | -8.36M | -8.3M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 1.43M | 3.55M | 0 |
| Operating Income | -2k | -31.9M | -32.4M | -33.84M |
| Net Income | -2k | 15.8M | -22.67M | -35.81M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 36.65M | 29.08M | 21.93M | 26.89M | 20.16M |
| Total Liabilities | 25.09M | 25.18M | 26.74M | 24.31M | 24.13M |
| Total Equity | 11.56M | 3.9M | -4.81M | 2.58M | -3.97M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 190k | 54.06M | 29.08M | 20.54M |
| Total Liabilities | 167k | 36.77M | 25.18M | 26.34M |
| Total Equity | 23k | 17.28M | 3.9M | -5.8M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -19.12M | -25.9M | -7.64M | -16.23M | -23.98M |
| Investing | -21.48M | -17.86M | 9.03M | 7.45M | 5.54M |
| Financing | 2.8M | 2.77M | 212k | 14.78M | 15.12M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1,000 | -24.89M | -25.9M | -29.55M |
| Investing | N/A | 565k | -17.86M | 14.48M |
| Financing | 13k | 58.81M | 2.77M | 21.23M |
| Market Cap | 5.51M |
| Price to Earnings Ratio | -0.15 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.36 |
| Price to Book Ratio | -0.94 |
| Dividend Yield | - |
| Shares Outstanding | 3M |
| Average Volume (1 week) | 155.65k |
| Average Volume (1 Month) | 883.96k |
| 52 Week Change | -81.13% |
| 52 Week High | 37.00 |
| 52 Week Low | 1.60 |
| Spread (Intraday) | 0.08 (4.32%) |
| Company Name | eFFECTOR Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.effector.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
